Literature DB >> 18475565

Modulation of cytokine production by carnitine.

N M Kouttab1, C De Simone.   

Abstract

The ability of carnitine congeners to modulate cytokine production by human peripheral blood mononuclear cells (PBMC) was investigated. Modulation of cytokine production by PBMC of young (30 years of age or younger) and old (70 years of age or older) normal donors was first compared. The PBMC were collected over Ficoll-Hypaque and incubated in the presence of various concentrations of acetyl L-carnitine for 24 h. Subsequently the supernatants were collected and examined for cytokine production. The presence of cytokines in tissue culture supernatants was examined by ELISA. The cytokines measured included IL-1alpha, IL-1beta, IL-2, IL-4, IL-6, TNFalpha, GM-CSF, and IFNgamma. The results showed that at 50 mug/ml of acetyl L-carnitine the most significant response was obtained for TNFalpha. In this regard four of five young donors responded, but only one of five old donors responded. More recently these studies were expanded to examine the ability of L-carnitine to modulate cytokine production at higher doses, 200 and 400 mug/ml, in young donors. The results of these studies showed that in addition to TNFalpha, significant production of IL-1beta and IL-6 was observed. These preliminary studies provide evidence that carnitine may modulate immune functions through the production of selected cytokines.

Entities:  

Year:  1993        PMID: 18475565      PMCID: PMC2365445          DOI: 10.1155/S0962935193000717

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  14 in total

Review 1.  Clinical use of carnitine. Past, present and future.

Authors:  N Siliprandi; F Di Lisa; R Menabó
Journal:  Adv Exp Med Biol       Date:  1990       Impact factor: 2.622

2.  Thymosin-like peptides as potential immunostimulants. Synthesis via the polymeric-reagent method.

Authors:  M Mokotoff; M Zhao; S M Roth; J A Shelley; J N Slavoski; N M Kouttab
Journal:  J Med Chem       Date:  1990-01       Impact factor: 7.446

3.  L-carnitine deficiency in AIDS patients.

Authors:  C De Simone; S Tzantzoglou; E Jirillo; A Marzo; V Vullo; E A Martelli
Journal:  AIDS       Date:  1992-02       Impact factor: 4.177

Review 4.  The therapeutic potential of carnitine in cardiovascular disorders.

Authors:  C J Pepine
Journal:  Clin Ther       Date:  1991 Jan-Feb       Impact factor: 3.393

5.  Spontaneous awakening from sleep in infants.

Authors:  H Schulz; R Massetani; I Fagioli; P Salzarulo
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1985-10

6.  Effects of acetyl-L-carnitine oral administration on lymphocyte antibacterial activity and TNF-alpha levels in patients with active pulmonary tuberculosis. A randomized double blind versus placebo study.

Authors:  E Jirillo; M Altamura; I Munno; N M Pellegrino; R Sabato; S Di Fabio; C De Simone
Journal:  Immunopharmacol Immunotoxicol       Date:  1991       Impact factor: 2.730

7.  cDNA cloning, sequence analysis, and chromosomal localization of the gene for human carnitine palmitoyltransferase.

Authors:  G Finocchiaro; F Taroni; M Rocchi; A L Martin; I Colombo; G T Tarelli; S DiDonato
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-15       Impact factor: 11.205

8.  Carnitine octanoyltransferase of mouse liver peroxisomes: properties and effect of hypolipidemic drugs.

Authors:  S O Farrell; L L Bieber
Journal:  Arch Biochem Biophys       Date:  1983-04-01       Impact factor: 4.013

9.  Carnitine stimulation of glucose oxidation in the fatty acid perfused isolated working rat heart.

Authors:  T L Broderick; H A Quinney; G D Lopaschuk
Journal:  J Biol Chem       Date:  1992-02-25       Impact factor: 5.157

10.  Molecular characterization of inherited carnitine palmitoyltransferase II deficiency.

Authors:  F Taroni; E Verderio; S Fiorucci; P Cavadini; G Finocchiaro; G Uziel; E Lamantea; C Gellera; S DiDonato
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

View more
  5 in total

1.  L-carnitine in a certain concentration increases expression of cell surface marker CD34 and apoptosis in the rat bone marrow CD34+ hematopoietic stem cells.

Authors:  E Fathi; M Kholosi Pashutan; R Farahzadi; H Nozad Charoudeh
Journal:  Iran J Vet Res       Date:  2021       Impact factor: 1.376

2.  L-carnitine, a diet component and organic cation transporter OCTN ligand, displays immunosuppressive properties and abrogates intestinal inflammation.

Authors:  G Fortin; K Yurchenko; C Collette; M Rubio; A-C Villani; A Bitton; M Sarfati; D Franchimont
Journal:  Clin Exp Immunol       Date:  2009-01-23       Impact factor: 4.330

3.  Effect of Genistein and L-carnitine and Their Combination on Lipid Profile and Inflammatory Cytokines in Experimental Nephrotic Syndrome.

Authors:  Abbas Yousefinejad; Fereydoon Siassi; Mohammad Hassan Javanbakht; Hamed Mohammadi; Ehsan Ghaedi; Mahnaz Zarei; Ehsan Djalali; Mahmoud Djalali
Journal:  Rep Biochem Mol Biol       Date:  2018-10

4.  Accumulation of Palmitoylcarnitine and Its Effect on Pro-Inflammatory Pathways and Calcium Influx in Prostate Cancer.

Authors:  Ala'a Al-Bakheit; Maria Traka; Shikha Saha; Richard Mithen; Antonietta Melchini
Journal:  Prostate       Date:  2016-07-12       Impact factor: 4.104

5.  Treatment With Lipopolysaccharide Induces Distinct Changes in Metabolite Profile and Body Weight in 129Sv and Bl6 Mouse Strains.

Authors:  Maria Piirsalu; Egon Taalberg; Kersti Lilleväli; Li Tian; Mihkel Zilmer; Eero Vasar
Journal:  Front Pharmacol       Date:  2020-03-27       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.